Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02764593
Title Chemotherapy +/- Nivolumab in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors RTOG Foundation, Inc.
Indications

oral squamous cell carcinoma

head and neck squamous cell carcinoma

hypopharynx cancer

laryngeal squamous cell carcinoma

oropharynx cancer

Therapies

Nivolumab

Cisplatin + Nivolumab

Cetuximab + Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.